TAIMEI TECH Adds 20,000 H Shares to Treasury, Lifting Total Buybacks to 6.88 Million

Bulletin Express
Sep 28

TAIMEI TECH (Zhejiang Taimei Medical Technology Co., Ltd.) disclosed a further on-market repurchase of 20,000 H shares on 28 September 2026 under its existing share-buyback mandate.

The shares were bought on the Hong Kong Stock Exchange at prices ranging from HKD 4.63 to HKD 4.995, with a volume-weighted average outlay of HKD 94,375. Following the transaction, the company’s treasury share balance rose to 7.30 million, while the number of issued shares outstanding slipped to 193.29 million—a marginal 0.01% reduction from the previous level.

Since receiving shareholder approval on 23 June 2026 to repurchase up to 20.02 million shares, TAIMEI TECH has accumulated 6.88 million repurchased shares, equivalent to 3.44% of the share count in place at the mandate date.

In line with Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share disposals until 28 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10